Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

Barry J. Maron, James E. Udelson, Robert O. Bonow, Rick A. Nishimura, Michael John Ackerman, N. A Mark Estes, Leslie T Jr. Cooper, Mark S. Link, Martin S. Maron

Research output: Contribution to journalArticle

87 Scopus citations
Original languageEnglish (US)
Pages (from-to)2362-2371
Number of pages10
JournalJournal of the American College of Cardiology
Volume66
Issue number21
DOIs
StatePublished - 2015

Keywords

  • ACC/AHA Scientific Statements
  • arrhythmogenic right ventricular cardiomyopathy
  • athletes
  • cardiomyopathy
  • cardiovascular abnormalities
  • cardiovascular magnetic resonance
  • hypertrophic cardiomyopathy
  • myocarditis
  • sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this